1. Home
  2. VERA vs CMPS Comparison

VERA vs CMPS Comparison

Compare VERA & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$29.79

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

N/A

Current Price

$11.71

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VERA
CMPS
Founded
2016
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
VERA
CMPS
Price
$29.79
$11.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
16
Target Price
★ $74.20
$23.75
AVG Volume (30 Days)
1.6M
★ 2.1M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$841.44
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.05
$4.88
52 Week High
$56.05
$15.87

Technical Indicators

Market Signals
Indicator
VERA
CMPS
Relative Strength Index (RSI) 47.73 47.04
Support Level $26.38 $11.56
Resistance Level $36.95 $12.08
Average True Range (ATR) 1.58 0.58
MACD 0.19 0.07
Stochastic Oscillator 58.65 72.86

Price Performance

Historical Comparison
VERA
CMPS

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Share on Social Networks: